Russian President Vladimir Putin said on Wednesday that life goes on despite a difficult COVID-19 situation in the country that has seen infection records for two weeks straight.
The Kremlin continues to hold off from imposing nationwide restrictions even as the state coronavirus task force reported 141,883 news infections on Wednesday -- a massive spike from the daily 15,000 cases recorded in early January.
Putin appealed for solidarity and mutual assistance to help the country pull through the renewed surge.
With only one six-week-long lockdown in 2020, Russia has avoided imposing nationwide COVID-19 restrictions on its citizens, leaving these decisions up to the local governments in its regions.
Restrictions vary from region to region in Russia, ranging from working remotely to limiting access to certain public spaces.
Already today we are not talking about the lockdown, we are not talking about the quarantine, we are not talking about some kind of emergency countermeasures, Anna Popova, the head of Russia's public health agency, told state-run news agency RIA Novosti.
Last month, parliament indefinitely postponed introducing restrictions on the unvaccinated that would have proven unpopular among vaccine-hesitant Russians.
And last week health officials cut the required isolation period for those who came in contact with COVID-19 patients from 14 days to seven without offering any explanation for the move.
Russia's state coronavirus task force reported 12,128,796 confirmed cases and 332,690 deaths since the start of the pandemic, the highest death toll in Europe by far.
Russia's state statistics agency Rosstat, which uses broader counting criteria than the task force, puts the country's pandemic death toll much higher, saying the number of virus-linked deaths between April 2020 and December 2021 was at about 681,100.
Just about half of Russia's 146 million people have been fully vaccinated, even though Russia boasted about being the first country in the world to approve and roll out a domestically developed coronavirus vaccine.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)